Diampa M 12.5/500mg Tablet – Empagliflozin 12.5mg + Metformin 500mg Dual Therapy for Type 2 Diabetes
Diampa M 12.5/500mg Tablet – Empagliflozin 12.5mg + Metformin 500mg Dual Therapy for Type 2 Diabetes
Diampa M 12.5/500mg Tablet – Empagliflozin 12.5mg + Metformin 500mg Dual Therapy for Type 2 Diabetes
Description
Diampa M 12.5/500mg Tablet – Perfect Starting-Strength Combination for Effective Glucose Control
Diampa M 12.5/500mg Tablet brings together Empagliflozin 12.5mg and Metformin 500mg in one film-coated tablet, offering a balanced and well-tolerated dual mechanism for adults newly stepping up from metformin monotherapy. Empagliflozin drives excess sugar out through urine while metformin reduces hepatic glucose output and enhances insulin utilization, resulting in meaningful HbA1c drops, gentle weight reduction, and the renowned cardiovascular and renal protective effects of the SGLT2 class – all with a lower metformin dose that minimizes early gastrointestinal discomfort.


